Clarence Deacon v. HHS - Influenza, Transverse Myelitis (2022)

Filed 2020-07-14Decided 2022-06-17Vaccine Influenza
compensated$77,171

Case summary [AI summaries can sometimes make mistakes]

Clarence Deacon filed a petition for compensation under the National Vaccine Injury Compensation Program on July 14, 2020, alleging that he suffered Transverse Myelitis (TM) caused-in-fact by his August 26, 2017 influenza vaccination. He further alleged that he experienced residual effects for more than six months.

The respondent denied that the flu vaccine caused petitioner's TM or its residual effects. Despite the denial, the parties filed a joint stipulation for damages on June 17, 2022.

Special Master Daniel T. Horner found the stipulation reasonable and adopted it as the decision of the Court.

Clarence Deacon was awarded $75,000.00 as a lump sum and $2,171.42 to reimburse a Medicaid lien, totaling $77,171.42. This compensation covers all items of damages available under § 15(a).

The public decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or expert witnesses. Ronald Craig Homer represented the petitioner, and Jennifer Reynaud represented the respondent.

Source PDFs 2 total · 2 downloaded